Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques

This publication has 29 references indexed in Scilit:

• Comparison of the Immunogenicity and Efficacy of a Replication‐Defective Vaccinia Virus Expressing Antigens of Human Parainfluenza Virus Type 3 (HPIV3) with Those of a Live Attenuated HPIV3 Vaccine Candidate in Rhesus Monkeys Passively Immunized with PIV3 Antibodies
  The Journal of Infectious Diseases, 1999
• Dosimetry for total body irradiation of rhesus monkeys with 300 kV X-rays
  International Journal of Radiation Biology, 1998
• Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model
  Vaccine, 1996
• Viral Replication and Development of Specific Immunity in Macaques after Infection with Different Measles Virus Strains
  The Journal of Infectious Diseases, 1994
• Administration of ATG according to the absolute T lymphocyte count during therapy for steroid-resistant rejection
  Transplant International, 1993
• The age-dependent risk of postvaccination complications in vaccinees with smallpox vaccine
  Vaccine, 1992
• Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence
  Journal of General Virology, 1991
• Disseminated Vaccinia in a Military Recruit with Human Immunodeficiency Virus (HIV) Disease
  New England Journal of Medicine, 1987
• Measles virus vaccination of measles seropositive individuals suppresses lymphocyte proliferation and chemotactic factor production
  Clinical Immunology and Immunopathology, 1981
• Studies on poxvirus infections in irradiated animals
  Archiv für die gesamte Virusforschung, 1980